William Dunn
Direktor/Vorstandsmitglied bei PROTHENA CORPORATION PLC
Ursprung des Netzwerks ersten Grades von William Dunn
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William Dunn
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Director/Board Member Chairman | |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal General Counsel | ||
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman | |
| Yale University | College/University | Undergraduate Degree | |
| University of Gothenburg | College/University | Doctorate Degree | |
| DIUL GROUP | Pharmaceuticals: Major | Chairman | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman | |
Latham & Watkins LLP
 Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Latham & Watkins LLP operates as a full-service law firm or legal matters. It offers services in the areas of finance, litigation, accounting, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The company was founded in 1934 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Pharmacia GmbH | Private Equity Investor | ||
| CODEMILL AB | Packaged Software | Comptroller/Controller/Auditor | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
| BRAIN+ A/S | Packaged Software | Chairman | |
| VIVESTO AB | Pharmaceuticals: Generic | Chairman | |
| Karolinska Institutet | College/University | Doctorate Degree | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Director/Board Member | |
HeiQ Materials AG
 HeiQ Materials AG TextilesProcess Industries HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland. | Textiles | Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| Serono International SA | Corporate Officer/Principal | ||
Arnold & Porter Kaye Scholer LLP
 Arnold & Porter Kaye Scholer LLP Miscellaneous Commercial ServicesCommercial Services Arnold & Porter Kaye Scholer LLP engages in the provision of legal services. It offers litigation and transactional capabilities; and regulatory experience and multidisciplinary practices in the life sciences and financial services industries. Its practice areas are comprised of bankruptcy, corporate finance, intellectual property, litigation, real estate and tax. The company was founded on January 1, 2017 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ADAMA Agriculture BV
 ADAMA Agriculture BV Chemicals: AgriculturalProcess Industries ADAMA Agriculture BV is a Dutch company that manufactures biocidal products for crop protection. The private company is based in Leusden, NL. and has subsidiaries in Italy, Romania, Czechia and United Kingdom. | Chemicals: Agricultural | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 27 |
| Schweden | 7 |
| Schweiz | 6 |
| Niederlande | 4 |
| Irland | 3 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 5 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 86 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 35 |
| Chairman | 27 |
| Undergraduate Degree | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Helen Kim | 33 |
| Daniel Welch | 24 |
| Karl Härfstrand | 23 |
| Lars Ekman | 21 |
| Dennis Selkoe | 16 |
| Oleg Nodelman | 15 |
| Shane Cooke | 13 |
| Tran Nguyen | 10 |
| Hideki Garren | 9 |
| Sanjiv Patel | 9 |
| Paula Cobb | 8 |
| Carol Karp | 8 |
| Michael J. Malecek | 8 |
| Karin Walker | 8 |
| Richard Collier | 7 |
- Börse
- Insiders
- William Dunn
- Unternehmensverbindungen
